Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06662149 · ClinicalTrials.gov registry record · NA

Exploring the Influence of Sensory Cues on Eating Behavior Using Virtual Reality

A NA study, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT06662149: Completed NA study, sponsored by Penn State University.

NCT06662149 is a NA study that has completed, run by Penn State University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06662149, a NA study, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

Many factors influence eating choices among humans (mood, taste, convenience, time of day, etc.). Finding simple ways to decrease food intake or improve food choices could improve weight status and overall health of the general population. The purpose of this study is to see if city and/or nature smells affect human eating behavior within a virtual reality-simulated outdoor café. The researchers of this study believe that a better understanding of how smells affect eating behavior could lead to public guidelines that direct the construction and layout of such outdoor eating environments to better support healthy behaviors.

Primary Outcome

Total weight of the meal and individual components of the meal are measured in grams before and after participant consumption. The difference is recorded as the amount consumed by the participant. Grams of food will be converted into kilocalories and reported as energy consumed as well.

Interventions

  • OTHER Pleasant Smell
  • OTHER Unpleasant Smell

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-12-15
Est. Completion 2025-08-01
Phase NA
Penn State University

219 total trials

What the finished NCT06662149 record still lists

NCT06662149 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Pleasant Smell is the first listed.

NCT06662149 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06662149 about?

NCT06662149 is a clinical study titled "Exploring the Influence of Sensory Cues on Eating Behavior Using Virtual Reality". Many factors influence eating choices among humans (mood, taste, convenience, time of day, etc.). Finding simple ways to decrease food intake or improve food choices could improve weight status and overall health of the general population. The purpose of this study is to see if city and/or nature sm...

What is the current status of trial NCT06662149?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2024-12-15. Estimated completion is 2025-08-01.

What interventions are being tested in trial NCT06662149?

The interventions under investigation include: Pleasant Smell (OTHER), Unpleasant Smell (OTHER).

Who is sponsoring clinical trial NCT06662149?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06662149's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06662149, the US trial registry maintained by the National Library of Medicine. NCT06662149 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.